CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,884,973 | -22.3% | 2,166,885 | 0.0% | 0.00% | – |
| Q2 2023 | $2,426,912 | +7.7% | 2,166,885 | 0.0% | 0.00% | – |
| Q1 2023 | $2,253,561 | -7.1% | 2,166,885 | 0.0% | 0.00% | – |
| Q4 2022 | $2,426,912 | -0.8% | 2,166,885 | +0.1% | 0.00% | – |
| Q3 2022 | $2,447,000 | -23.1% | 2,165,677 | 0.0% | 0.00% | – |
| Q2 2022 | $3,183,000 | -35.8% | 2,165,677 | 0.0% | 0.00% | – |
| Q1 2022 | $4,960,000 | -17.1% | 2,165,677 | -0.4% | 0.00% | – |
| Q4 2021 | $5,982,000 | -54.2% | 2,175,152 | -0.1% | 0.00% | – |
| Q3 2021 | $13,069,000 | +27.4% | 2,178,172 | +3.4% | 0.00% | – |
| Q2 2021 | $10,256,000 | +140.4% | 2,106,090 | +21.9% | 0.00% | – |
| Q1 2021 | $4,267,000 | -7.9% | 1,727,531 | +2.2% | 0.00% | – |
| Q4 2020 | $4,633,000 | +83.2% | 1,690,741 | +2.9% | 0.00% | – |
| Q3 2020 | $2,529,000 | -15.5% | 1,642,664 | +3.2% | 0.00% | – |
| Q2 2020 | $2,993,000 | +7.7% | 1,592,096 | -2.7% | 0.00% | – |
| Q1 2020 | $2,780,000 | -9.6% | 1,635,445 | +54.2% | 0.00% | – |
| Q4 2019 | $3,075,000 | +371.6% | 1,060,390 | +2.5% | 0.00% | – |
| Q3 2019 | $652,000 | -27.5% | 1,034,665 | +11.9% | 0.00% | – |
| Q2 2019 | $899,000 | +17.7% | 924,485 | +66.9% | 0.00% | – |
| Q1 2019 | $764,000 | +27.8% | 553,795 | -1.0% | 0.00% | – |
| Q4 2018 | $598,000 | -92.3% | 559,605 | -55.4% | 0.00% | – |
| Q3 2018 | $7,723,000 | -41.2% | 1,255,662 | +2.2% | 0.00% | -100.0% |
| Q2 2018 | $13,132,000 | +6.5% | 1,228,484 | +6.9% | 0.00% | 0.0% |
| Q1 2018 | $12,325,000 | +128.0% | 1,148,715 | +48.8% | 0.00% | – |
| Q4 2017 | $5,406,000 | -14.1% | 772,215 | +7.2% | 0.00% | – |
| Q3 2017 | $6,295,000 | -1.5% | 720,257 | +2.7% | 0.00% | – |
| Q2 2017 | $6,391,000 | +27.5% | 701,550 | +11.2% | 0.00% | – |
| Q1 2017 | $5,011,000 | -4.3% | 631,062 | +7.8% | 0.00% | – |
| Q4 2016 | $5,234,000 | -9.1% | 585,405 | +76.5% | 0.00% | – |
| Q3 2016 | $5,756,000 | – | 331,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |